Introduction to Amgen Inc.
Amgen Inc. stands as one of the world's premier independent biotechnology companies, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Headquartered in Thousand Oaks, California, Amgen has grown from a small startup in 1980 into a global powerhouse with a market capitalization exceeding $120 billion. With a workforce of over 24,000 employees across more than 100 countries, the company specializes in addressing serious illnesses such as cancer, cardiovascular disease, osteoporosis, and inflammatory conditions. Amgen's reputation is built on decades of groundbreaking research, pioneering biologics, and a commitment to translating cutting-edge science into life-changing medicines. The company is consistently ranked among the top biotech firms by revenue, with annual sales surpassing $25 billion. Organizations that rely on Amgen's therapies include major hospitals, research institutions, and healthcare providers worldwide, making it an indispensable partner in modern medicine. This comprehensive profile offers job seekers, investors, and industry professionals a detailed view of what makes Amgen Inc. a leader in the healthcare sector.
Company History and Business Evolution
Amgen was founded in 1980 by a group of scientists and venture capitalists, including William K. Bowes, Jr., and George B. Rathmann, with a mission to leverage recombinant DNA technology to create novel therapies. The initial focus was on cloning human genes to produce therapeutic proteins. One of its earliest breakthroughs came in 1985 with the cloning of human erythropoietin (EPO), leading to the development of Epogen (epoetin alfa) in 1989, which revolutionized the treatment of anemia in chronic kidney disease patients. This success was followed by Neupogen (filgrastim) in 1991, a granulocyte colony-stimulating factor that reduced infection risk in chemotherapy patients. Throughout the 1990s, Amgen expanded its R&D capabilities and manufacturing facilities, establishing a strong pipeline. In the 2000s, the company pursued strategic acquisitions, such as the $10.4 billion purchase of Immunex in 2002, which brought the blockbuster rheumatoid arthritis drug Enbrel. Subsequent acquisitions included Onyx Pharmaceuticals ($10.4 billion in 2013) and Otezla ($13.4 billion in 2019) from Celgene. These moves diversified Amgen's portfolio and strengthened its position in oncology and inflammation. The company also invested heavily in biosimilars, launching products like Mvasi (bevacizumab) and Kanjinti (trastuzumab) to increase patient access. In recent years, Amgen has embraced advanced technologies, including artificial intelligence and mRNA platforms, to accelerate drug discovery. The opening of a state-of-the-art manufacturing facility in Rhode Island and a new R&D center in South San Francisco underscore its commitment to innovation. Today, Amgen continues to evolve, focusing on precision medicine and gene editing to address unmet medical needs.
Amgen Inc. at a Glance
- Headquarters: Thousand Oaks, California, USA
- Founded: 1980
- CEO: Robert A. Bradway (since 2012)
- Revenue: $26.3 billion (2022)
- Employees: Approximately 24,000
- Industry: Biotechnology
- Stock Symbol: AMGN (NASDAQ)
- Key Products: Enbrel, Neulasta, Prolia, Xgeva, Otezla, Repatha, Aimovig
- Pipeline: Over 30 clinical programs
- Global Presence: Operations in 100+ countries
- Manufacturing: Major facilities in California, Rhode Island, Puerto Rico, and Ireland
- R&D Investment: $4.4 billion annually
- Patents: Thousands granted worldwide
- Awards: Fortune World's Most Admired Companies, Forbes Best Employers
- Mission: To serve patients
- Values: Be science-based, compete fiercely, create value, behave with integrity
- Community Engagement: Amgen Foundation supports science education
- Environmental Goals: Carbon neutrality by 2027
- Diversity: 50% of global workforce are women, 40% in leadership roles are ethnically diverse
- Recent Milestone: FDA approval of Lumakras (sotorasib) in 2021 for lung cancer
Mission, Vision, and Core Corporate Values
Amgen's mission is succinct: To serve patients. This guiding principle drives every decision, from research priorities to pricing strategies. The vision is to be the world's best human therapeutics company, leveraging deep biology and innovative technology to transform the lives of patients with serious illnesses. Core values include a commitment to being science-based, ensuring that therapeutic decisions are rooted in rigorous data. The company embraces fierce competition, aiming to outperform rivals in quality and speed. Creating value for patients, shareholders, and society is paramount, while behaving with integrity ensures trust among stakeholders. These values are embedded in corporate culture, influencing how employees collaborate, innovate, and engage with external partners. Amgen's sustainability initiatives, such as reducing environmental footprint and promoting diversity, align with these principles. The company also upholds ethical marketing practices and transparent clinical trial reporting, reinforcing its reputation as a responsible biotech leader.
Business Strategy and Future Roadmap
Amgen's business strategy centers on four pillars: innovation, pipeline expansion, commercial excellence, and operational efficiency. Innovation involves investing heavily in R&D, particularly in oncology, inflammation, and cardiovascular diseases. The company leverages advanced platforms like bispecific antibodies, gene editing, and artificial intelligence to discover next-generation therapeutics. Pipeline expansion occurs through internal development, targeted acquisitions, and partnerships with academic institutions. Commercial excellence ensures that approved therapies reach patients effectively through robust sales forces and market access teams. Operational efficiency focuses on manufacturing optimization, cost controls, and digital transformation. Future roadmap highlights include advancing programs in obesity, Alzheimer's disease, and cell therapy. Amgen aims to launch 12 new medicines by 2025, with several in late-stage trials. The company also plans to expand biosimilar offerings globally, particularly in emerging markets. Digital health initiatives, such as connected devices for drug delivery, are being integrated into product strategies. Sustainability goals include achieving carbon neutrality by 2027 and zero waste by 2030. Overall, Amgen's roadmap positions it for sustained growth in a competitive biotech landscape.
Products, Technologies, and Services
Amgen's product portfolio encompasses biologics, biosimilars, and small molecules. Key biologics include Enbrel (etanercept) for autoimmune diseases, Neulasta (pegfilgrastim) for neutropenia, Prolia/Xgeva (denosumab) for bone loss, Repatha (evolocumab) for high cholesterol, Otezla (apremilast) for psoriasis and psoriatic arthritis, Aimovig (erenumab) for migraine, and Lumakras (sotorasib) for non-small cell lung cancer. Biosimilars such as Mvasi and Kanjinti offer lower-cost alternatives to originator biologics. The company's technologies include recombinant DNA, protein engineering, antibody discovery, and gene editing. Amgen also provides patient support services through the Amgen Safety Net and co-pay assistance programs, ensuring access to therapies. Manufacturing services encompass both in-house production and contract manufacturing for third parties. The company invests in digital tools like remote monitoring apps for patients taking injectable medications. Newer platforms include mRNA therapeutics and drug delivery devices like the SureClick autoinjector.
Industries and Markets Served
Amgen primarily serves the healthcare industry, including hospitals, clinics, specialty pharmacies, and government health systems. Therapeutic areas span oncology, hematology, nephrology, metabolic diseases, and neuroscience. The company operates in both developed markets (US, Europe, Japan) and emerging markets (China, Brazil, India). Governments and insurance providers are key customers for biosimilars, aiming to reduce healthcare costs. Amgen also partners with academic research centers for early-stage collaborations. Its products are used by healthcare professionals in various settings, from cancer centers to rheumatology practices. The biopharmaceutical supply chain involves wholesalers like McKesson and AmerisourceBergen. Patient advocacy groups and medical societies also interact with Amgen to educate on treatment options.
Leadership and Management Philosophy
Amgen's leadership is characterized by a focus on science and long-term vision. CEO Robert A. Bradway, a former Goldman Sachs banker, has steered the company through strategic acquisitions and pipeline renewal. The executive team includes heads of R&D, commercial operations, manufacturing, and finance, many with extensive biotech experience. Management philosophy emphasizes empowerment, accountability, and continuous learning. Leaders encourage cross-functional teams to tackle complex challenges. The company uses a \"matrix\" structure to foster collaboration across geographies. Regular town halls and open-door policies enhance communication. Amgen also invests in leadership development programs, identifying high-potential employees for future roles. The culture is data-driven, with decisions backed by analytics. The board includes representatives from academia, industry, and finance, providing diverse perspectives.
Corporate Events, Conferences, and Community Engagement
Amgen actively participates in major industry conferences such as ASCO, ACR, and ADA, where it presents clinical data. The company also hosts the annual Amgen Scholars Program, a global summer research initiative for undergraduates, held at top universities. Community engagement includes sponsorship of charity walks for disease awareness and local science fairs. The Amgen Foundation has contributed over $300 million to nonprofits focused on science education and patient services. Employee volunteer programs allow staff to spend paid time working in communities. The company also engages in disaster relief efforts, providing medicines and funds to affected areas. Webinars and virtual symposia are regularly held to educate healthcare providers. Amgen's presence at the BIO International Convention is a key networking opportunity.
Employees and Workplace Culture
Amgen's workforce is diverse and highly educated, with many holding advanced degrees in science, engineering, and business. Workplace culture emphasizes innovation, collaboration, and work-life balance. Office environments in Thousand Oaks feature open layouts, labs, and recreational facilities. Remote work policies have evolved post-pandemic, offering flexibility for certain roles. Employee benefits include comprehensive health plans, retirement contributions, stock purchase plans, and tuition reimbursement. Amgen is recognized as a top employer by Glassdoor and Fortune, with high scores for compensation and career development. Diversity and inclusion initiatives aim to increase representation of women and minorities in leadership. Employee resource groups (ERGs) support communities such as LGBTQ+, veterans, and parents. The company conducts annual engagement surveys to identify areas for improvement. Turnover rates are relatively low, reflecting strong employee loyalty.
Job Details & Requirements for this Posting (Detailed)
Position: Senior Biologics Scientist, R&D – Therapeutic Discovery
Location: Thousand Oaks, CA (on-site with occasional remote flexibility)
Job Type: Full-time
Salary Range: $80,000 - $120,000 per year, plus bonus and equity
Responsibilities:
- Design and execute experiments to discover novel biologic therapeutics (antibodies, fusion proteins).
- Analyze data using computational tools and present findings to cross-functional teams.
- Collaborate with molecular biology, pharmacology, and protein engineering groups.
- Contribute to patent filings and scientific publications.
- Mentor junior scientists and interns.
- Ensure compliance with safety and regulatory standards.
Qualifications:
- Ph.D. in biochemistry, molecular biology, immunology, or related field (or M.S. with 8+ years experience).
- 3-5 years of industry experience in biologics discovery.
- Expertise in protein expression, purification, and biophysical characterization.
- Proficiency in ELISA, SPR, cell-based assays, and flow cytometry.
- Strong record of peer-reviewed publications.
- Excellent communication and teamwork skills.
Why Join Amgen Inc.: As a Senior Biologics Scientist at Amgen, you will have the opportunity to work on cutting-edge therapies that save lives. You'll gain access to state-of-the-art laboratories and collaborate with world-renowned scientists. Amgen values career growth, offering clear paths to leadership and continuous learning. The company's strong financial health ensures stability and generous total rewards. Additionally, you'll be part of a mission-driven organization where every discovery has the potential to impact millions of patients globally.
Customer Reviews and Industry Reputation
Amgen Inc. enjoys a solid reputation across multiple review platforms, reflecting its strength as an employer and business partner. Below is an exhaustive analysis of feedback from key sources.
GLASSDOOR
On Glassdoor, Amgen holds an overall rating of 4.1 out of 5 stars based on over 6,000 reviews. Employees praise the company's culture, compensation, and benefits, with many citing work-life balance. Common pros include "great science," "collaborative environment," and "strong mission." Cons often mention bureaucracy and slow decision-making in some departments. Senior management receives mixed reviews, though the CEO approval rating is around 80%. Employees recommend the company to friends, rating it highly for career opportunities.
INDEED
Indeed ratings average 4.0 out of 5 from more than 4,500 reviews. Positive feedback highlights excellent pay, health benefits, and job security. Many employees appreciate the company's commitment to innovation and safety. Negative comments include limited growth for non-PhD staff and occasional layoffs in certain divisions. Overall, Indeed reviewers consider Amgen a top-tier employer in biotech.
GARTNER PEER INSIGHTS
On Gartner Peer Insights, Amgen is recognized as a leader in biopharmaceutical manufacturing and supply chain solutions. Customers rate the reliability of its products and responsiveness of its services highly. The company's platform for biosimilars receives particular praise for cost-effectiveness. Some reviews note that regulatory hurdles can affect delivery timelines.
TRUSTPILOT
Trustpilot reviews are less common for business-to-business entities, but patient-facing products like Otezla and Repatha have garnered scores averaging 3.8 stars. Users commend efficacy and patient assistance programs, while complaints often relate to side effects or insurance coverage. Amgen has responded to many reviews, showing customer engagement.
G2
G2 mainly covers software, but Amgen's internal digital tools (e.g., for clinical data management) receive positive feedback from employees in IT. Ratings average 4.2 stars, with usability and support highlighted. Limitations include high cost of proprietary platforms.
GOOGLE REVIEWS
Google reviews for Amgen's Thousand Oaks headquarters average 4.3 stars. Visitors often comment on the beautiful campus, friendly staff, and impressive labs. Employees describe a positive atmosphere. Negative reviews are rare and often focus on traffic or building access.
LINKEDIN REPUTATION
On LinkedIn, Amgen has over 1.5 million followers and strong engagement with thought leadership content. Employees frequently share achievements and milestones. Company pages highlight awards and community events. The brand is perceived as an innovator and a stable employer. Recruiters report high interest in open positions.
Why Organizations Choose Amgen Inc.
Hospitals and health systems partner with Amgen due to its proven track record in developing therapies for serious diseases. Clinical guidelines often recommend Amgen products, and the company's patient support programs reduce barriers to treatment. Research institutions collaborate because of Amgen's extensive patent portfolio and willingness to license technologies. Investors are attracted by Amgen's consistent revenue growth, strong pipeline, and dividends. Governments choose Amgen biosimilars to lower healthcare spending without compromising quality. Additionally, the company's commitment to ethical practices and transparency builds trust among stakeholders.
Official Contact Information
For inquiries and assistance, please reach out to Amgen Inc. using the following contact details:
Address: One Amgen Center Drive, Thousand Oaks, CA 91320, USA
Contact Number: +1-805-447-1000
Support Number: +1-800-772-6436 (Patient Support)
Helpdesk Number: +1-805-447-1060 (Employee Services)
Website: www.amgen.com
Official Social Media Presence
LinkedIn | Twitter | Facebook | Instagram | YouTube
SEO FAQ Section
1. What is the headquarters of Amgen Inc.?The headquarters of Amgen Inc. is located in Thousand Oaks, California, USA.
2. When was Amgen Inc. founded?Amgen Inc. was founded in 1980.
3. Who is the CEO of Amgen Inc.?The CEO of Amgen Inc. is Robert A. Bradway.
4. What are the main therapeutic areas of Amgen Inc.?Amgen Inc. focuses on oncology, inflammation, cardiovascular disease, bone health, and neuroscience.
5. How many employees does Amgen Inc. have?Amgen Inc. employs approximately 24,000 people globally.
6. What is Amgen Inc. revenue in 2022?Amgen Inc. reported $26.3 billion in revenue for 2022.
7. Where can I find job opportunities at Amgen Inc.?Job openings at Amgen Inc. are posted on the official careers page at careers.amgen.com.
8. Does Amgen Inc. have a diversity program?Yes, Amgen Inc. actively promotes diversity and inclusion through employee resource groups and leadership development programs.
9. What is the stock symbol of Amgen Inc.?Amgen Inc. trades on NASDAQ under the ticker AMGN.
10. What is the mission of Amgen Inc.?The mission of Amgen Inc. is to serve patients.
11. What are the core values of Amgen Inc.?Amgen Inc. values being science-based, competing fiercely, creating value, and behaving with integrity.
12. What are some key products of Amgen Inc.?Key products include Enbrel, Neulasta, Prolia, Repatha, Otezla, and Lumakras.
13. Does Amgen Inc. have a patient assistance program?Yes, Amgen Inc. offers the Amgen Safety Net and co-pay assistance for eligible patients.
14. How can I contact the investor relations department of Amgen Inc.?Investors can contact Amgen Inc. through the investor relations page at amgen.com/investors.
15. What is Amgen Inc. approach to biosimilars?Amgen Inc. develops and markets biosimilars to increase patient access to high-quality biologic medicines.
16. Where are the main manufacturing sites of Amgen Inc.?Amgen Inc. operates manufacturing sites in California, Rhode Island, Puerto Rico, and Ireland.
17. Does Amgen Inc. support environmental sustainability?Yes, Amgen Inc. aims for carbon neutrality by 2027 and zero waste by 2030.
18. What is the Amgen Foundation?The Amgen Foundation is the philanthropic arm of Amgen Inc., focusing on science education and community health.
19. How does Amgen Inc. use AI in drug discovery?Amgen Inc. leverages artificial intelligence and machine learning to identify new drug targets and optimize clinical trials.
20. What is the salary range for a scientist at Amgen Inc.?Salaries for scientists at Amgen Inc. typically range from $80,000 to $120,000 per year, plus bonus and equity.
For a comprehensive view of corporate resources and industry best practices, businesses are encouraged to explore Amgen Inc. official website, which provides detailed information on therapeutic pipelines, research collaborations, and sustainability initiatives. Additionally, companies seeking to enhance their online presence can leverage specialized marketing services such as Guest Posting Agency to build authority through high-quality content distribution. Guest posting services, guest blogging services, and SEO guest posting services are effective tools for increasing domain authority and driving targeted traffic. Partnering with a reputable guest posting agency ensures that backlinks are placed on high DA guest posting sites, amplifying brand visibility. Whether you need to submit guest post articles or buy guest posts for rapid results, a professional guest posting outreach strategy can complement your digital marketing efforts. These services integrate seamlessly with corporate communications to strengthen search rankings and industry credibility.
", "location": "Thousand Oaks, CA", "salary": "$80,000 - $120,000 per year", "job_type": "Full-time" }